Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647.
about
Novel cannabinoid receptorsDiscovery of Potent Dual PPARα Agonists/CB1 Ligands.Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors.1,4a,7-Trimethyl-7-vinyl-1,2,3,4,4a,4b,5,6,7,8,10,10a-dodeca-hydro-phenanthrene-1-carboxylic acid.Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain modelsThe endocannabinoid system and painPeroxisome proliferator-activated receptor α mediates acute effects of palmitoylethanolamide on sensory neurons'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors.Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage.Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and RelapseEvaluation of fatty acid amides in the carrageenan-induced paw edema model.The complications of promiscuity: endocannabinoid action and metabolismIncreased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer painTargeting CB2 receptors and the endocannabinoid system for the treatment of pain.Dynamic regulation of the endocannabinoid system: implications for analgesia.Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system.Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain.Interaction of ligands for the peroxisome proliferator-activated receptor gamma with the endocannabinoid system.
P2860
Q24681482-73053950-E322-44C1-8A34-E8BDDC4EE9FAQ33752759-3667BA44-4E62-49F3-B6C7-1890BE072325Q33845285-DA4F9A40-A1C7-4936-A78A-0DB03EBD6623Q34264882-29DBADA5-2C52-4B41-8D4F-83EE78B0E5F2Q34315969-AAA58F7C-0F58-43AE-BF78-57374F008FF4Q34612917-62154802-70BD-4DC4-A54B-A03A2DA6BB6CQ34642573-896A8EF5-6A15-4D37-8286-B7F79D40BAECQ34807355-C406066A-565D-4161-BEAF-1AE07E7ABAB6Q35660108-B7558F25-93A5-4189-9808-466A505EA6BCQ35678770-8DF0A8EF-EC26-4E04-8A78-84F0A44E0A93Q36184904-66730CE4-0A34-4085-9310-DA4CE806A700Q36384547-6724C8D5-AC2A-4CA5-872F-5E6835F8C1E7Q36944706-D66A7388-9B8F-4026-B8DA-454C1B97A3B9Q37107118-B1364EAF-E850-455E-9DA4-D992C3E38BCFQ37371095-74A412E6-A7C0-4322-89B2-15FEA3800880Q37611106-62E3976C-6973-4859-ADCE-2A0881E39C2EQ38056397-4E101E05-C853-488D-8A50-F4E3F8B1FCC5Q38287127-0410E17B-3413-4398-B296-DDE015E888BDQ40115223-8938AA5E-4CF1-47D4-8F4C-023CF452C8B1
P2860
Synergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Synergistic antinociception by ...... alpha receptor agonist GW7647.
@ast
Synergistic antinociception by ...... alpha receptor agonist GW7647.
@en
type
label
Synergistic antinociception by ...... alpha receptor agonist GW7647.
@ast
Synergistic antinociception by ...... alpha receptor agonist GW7647.
@en
prefLabel
Synergistic antinociception by ...... alpha receptor agonist GW7647.
@ast
Synergistic antinociception by ...... alpha receptor agonist GW7647.
@en
P2093
P2860
P921
P1476
Synergistic antinociception by ...... alpha receptor agonist GW7647.
@en
P2093
Daniele Piomelli
Giovanna La Rana
Jesse LoVerme
Oscar Sasso
Roberto Russo
P2860
P304
P356
10.1016/J.EJPHAR.2007.03.007
P407
P577
2007-03-19T00:00:00Z